XML 17 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Sep. 29, 2018
Sep. 30, 2017
OPERATING ACTIVITIES:    
Net loss $ (15.3) $ (7.6)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation expense 9.9 8.4
Amortization of acquired technologies and other intangibles 19.2 7.2
Stock-based compensation 8.1 7.5
Amortization of debt issuance costs and accretion of debt discount 6.9 9.8
Amortization of discount and premium on investments, net (0.2) (0.1)
Loss on disposal of assets 0.4 0.8
Loss on extinguishment of debt 0.0 3.6
Other (0.1) 0.7
Changes in operating assets and liabilities, net of impact of acquisitions of businesses:    
Accounts receivable (6.6) 4.7
Inventories 1.4 (12.1)
Other current and non-currents assets (3.0) 9.0
Accounts payable 3.7 4.5
Income taxes payable 1.3 (5.8)
Deferred revenue, current and non-current 1.1 (5.3)
Deferred taxes, net (1.9) (4.6)
Accrued payroll and related expenses 2.6 (2.0)
Accrued expenses and other current and non-current liabilities 0.1 (7.7)
Net cash provided by operating activities 27.6 11.0
INVESTING ACTIVITIES:    
Purchases of available-for-sale investments 0.0 (150.4)
Maturities of available-for-sale investments 36.5 140.6
Sales of available-for-sale investments 81.0 11.2
Capital expenditures (12.1) (8.4)
Proceeds from the sale of assets 1.6 0.9
Acquisition of businesses, net of cash acquired 0.0 (55.3)
Net cash provided by (used in) investing activities 107.0 (61.4)
FINANCING ACTIVITIES:    
Payment of debt issuance costs (0.5) 0.0
Repurchase and retirement of common stock 0.0 (9.2)
Withholding tax payment on vesting of restricted stock awards (5.5) (5.2)
Repurchase and redemption of convertible debt (134.3) (162.0)
Payment of financing obligations (0.2) (0.7)
Proceeds from exercise of employee stock options and employee stock purchase plan 2.1 2.5
Net cash used in financing activities (138.4) (174.6)
Effect of exchange rates on cash and cash equivalents (7.2) 9.1
Net decrease in cash, cash equivalents and restricted cash (11.0) (215.9)
Cash, cash equivalents and restricted cash at the beginning of the period [1] 624.3 1,022.4
Cash, cash equivalents and restricted cash at the end of the period [2] $ 613.3 $ 806.5
[1] These amounts include both current and non-current balances of restricted cash totaling $12.9 million and $18.0 million as of September 29, 2018 and September 30, 2017, respectively, which primarily represent collateral for letters of credit and performance bonds for the benefit of third parties.
[2] These amounts include both current and non-current balances of restricted cash totaling $12.6 million and $13.7 million as of September 29, 2018 and September 30, 2017, respectively, which primarily represent collateral for letters of credit and performance bonds for the benefit of third parties.